Federal Data Hub › HRSA 340B · JSON
340B ID CAH241343-00
ParticipatingCritical Access Hospital
AVERA GRANITE FALLS is a Critical Access Hospital enrolled in the federal 340B Drug Pricing Program in GRANITE FALLS, MN. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 19 contract-pharmacy arrangement(s) (9 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.
| Pharmacy | Location | Begin | Terminated | Pharmacy ID |
|---|---|---|---|---|
| AVERA SPECIALTY PHARMACY | SIOUX FALLS, SD | 2023-01-17 | — | 2295 |
| HY-VEE PHARMAACY 1400 | MARSHALL, MN | 2019-07-01 | — | 2742 |
| OPTUM INFUSION SERVICES 305, LLC | LENEXA, KS | 2025-10-01 | 2025-09-15 | 62882 |
| OPTUM PHARMACY 701, LLC | MESA, AZ | 2025-10-01 | 2025-09-15 | 137427 |
| OPTUM PHARMACY 702, LLC | JEFFERSONVILLE, IN | 2025-10-01 | 2025-09-15 | 90281 |
| OPTUM PHARMACY 705, LLC | BIRMINGHAM, AL | 2025-10-01 | 2025-09-15 | 43586 |
| OPTUMRX | OVERLAND PARK, KS | 2025-10-01 | 2025-09-15 | 62851 |
| SHOPKO PHARMACY #2025 | MARSHALL, MN | 2018-04-01 | 2018-12-19 | 57901 |
| SHOPKO PHARMACY #2748 | PIPESTONE, MN | 2018-04-01 | 2020-01-01 | 57855 |
| THRIFTY WHITE DRUG #760 | GRANITE FALLS, MN | 2017-10-01 | — | 57896 |
| THRIFTY WHITE PARTNERS IN CARE | FARGO, ND | 2022-10-01 | 2026-06-10 | 135206 |
| WAL-MART CENTRAL FILL 10-2670 | SPRING, TX | 2020-07-01 | — | 70688 |
| WAL-MART PHARMACY 10-1722 | MARSHALL, MN | 2018-01-01 | — | 7153 |
| WAL-MART PHARMACY 10-1858 | MONTEVIDEO, MN | 2018-01-01 | — | 57903 |
| WAL-MART PHARMACY 10-5997 | ORLANDO, FL | 2020-07-01 | — | 39270 |
| WALMART PHARMACY 10-5169 | ROGERS, AR | 2023-04-01 | — | 66076 |
| WHITE DRUG #52 | FARGO, ND | 2017-10-01 | 2022-06-27 | 6413 |
| WHITE DRUG #61 | FARGO, ND | 2017-10-01 | 2026-06-10 | 6412 |
| Walmart Pharmacy 10-7611 | Plainfield, IN | 2024-01-01 | — | 140224 |
Click a Pharmacy ID to see every other 340B entity using that same pharmacy.
The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.
Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.